» Articles » PMID: 40071159

Pathogenic Variants in and Genes Associated with Female Breast and Ovarian Cancer in the Mexican Population

Abstract

Breast and ovarian cancers are significant global health challenges, with inherited variations in breast cancer gene 1 () and breast cancer gene 2 () substantially increasing the risk, aggressiveness, and early onset of these diseases. This work aimed to examine pathogenic variants (PVs) in and databases that include Mexican populations. A systematic review of literature and data mining spanning from 2002 to 2023 was conducted. Articles published in journals indexed in SCImago quartiles Q1 to Q4 were screened. Databases were paired, standardized, and enriched with data from reputable global platforms: Genome Data Viewer, dbSNP, ClinVar, gnomAD browser, Breast Cancer Information Core (BIC), ClinGen, Varsome, Human Genome Variation Society (HGVS), Bioproject, Ensembl, Gene NIH NCIB, UniProt, and BRCA Exchange. Outcomes included data from 9,026 Mexican genotypes, identifying 657 PVs. Genetic mapping revealed certain exons, notably exon 10 of and exon 11 of , as highly mutagenic hot spots. The most frequent alteration was a large deletion in (ex9-12del), associated with a founder effect originating from a common Mexican ancestor. Finally, we constructed a genetic map containing all the single nucleotide variants (SNVs) and large rearrangements presented in the analyzed databases.

References
1.
Ossa Gomez C, Achatz M, Hurtado M, Sanabria-Salas M, Sullcahuaman Y, Chavarri-Guerra Y . Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study. JCO Glob Oncol. 2022; 8:e2200104. PMC: 9812461. DOI: 10.1200/GO.22.00104. View

2.
Torres-Mejia G, Royer R, Llacuachaqui M, Akbari M, Giuliano A, Martinez-Matsushita L . Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer. Cancer Epidemiol Biomarkers Prev. 2014; 24(3):498-505. PMC: 4495576. DOI: 10.1158/1055-9965.EPI-13-0980. View

3.
Fu X, Tan W, Song Q, Pei H, Li J . BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies. Front Cell Dev Biol. 2022; 10:813457. PMC: 8921524. DOI: 10.3389/fcell.2022.813457. View

4.
Calderon-Garciduenas A, Ruiz-Flores P, Cerda-Flores R, Barrera-Saldana H . Clinical follow up of mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes. Salud Publica Mex. 2005; 47(2):110-5. DOI: 10.1590/s0036-36342005000200004. View

5.
Villarreal-Garza C, Alvarez-Gomez R, Perez-Plasencia C, Herrera L, Herzog J, Castillo D . Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. Cancer. 2014; 121(3):372-8. PMC: 4304938. DOI: 10.1002/cncr.29058. View